Back to top

vaccines: Archive

Zacks Equity Research

U.S. Govt. Cancels $766M Funding Contract for Moderna's Bird Flu Shot

The government scraps funding deal for MRNA's bird flu shot, despite encouraging safety and efficacy data from early clinical studies on the vaccine.

MRNAPositive Net Change AGENPositive Net Change ADPTPositive Net Change

Sundeep Ganoria

Novo Nordisk vs. Viking Therapeutics: Which GLP-1 Stock Has More Upside?

With VKTX surging on clinical results and NVO investing to cement market share, investors face a high-stake GLP-1 showdown.

NVONegative Net Change LLYPositive Net Change VKTXPositive Net Change

Zacks Equity Research

MRNA Seeks FDA Nod for Updated COVID-19 Vaccine

Moderna files with FDA for updated Spikevax aimed at the LP.8.1 variant, which makes up 70% of U.S. COVID-19 cases.

PFEPositive Net Change MRNAPositive Net Change NVAXPositive Net Change BNTXPositive Net Change

Zacks Equity Research

MRNA Stock Down on Withdrawal of FDA Filing for COVID-Flu Combo Shot

Moderna's voluntary withdrawal of the filing stems from the FDA's request for vaccine efficacy data from a phase III study on the experimental flu shot.

SNYNegative Net Change PFEPositive Net Change MRNAPositive Net Change NVAXPositive Net Change

Sundeep Ganoria

MRNA, PFE Stocks Jump Despite FDA's Stricter Standards for COVID-19 Shots

Though the new FDA rules limit access to COVID-19 booster vaccines, the commitment to high-risk groups lifts Moderna, Pfizer and BioNTech stocks.

PFEPositive Net Change MRNAPositive Net Change BNTXPositive Net Change

Zacks Equity Research

NVAX Stock Surges on Securing FDA Approval for COVID-19 Vaccine

The FDA grants full approval to Novavax's protein-based COVID-19 vaccine after nearly a two-month delay, albeit with some new conditions.

SNYNegative Net Change PFEPositive Net Change MRNAPositive Net Change NVAXPositive Net Change